253 related articles for article (PubMed ID: 31420766)
1. The prognostic impact of lymph node metastasis in patients with non-small cell lung cancer and distant organ metastasis.
Yang J; Peng A; Wang B; Gusdon AM; Sun X; Jiang G; Zhang P
Clin Exp Metastasis; 2019 Oct; 36(5):457-466. PubMed ID: 31420766
[TBL] [Abstract][Full Text] [Related]
2. Prognostic impacts of extracranial metastasis on non-small cell lung cancer with brain metastasis: A retrospective study based on surveillance, epidemiology, and end results database.
Wang M; Wu Q; Zhang J; Qin G; Yang T; Liu Y; Wang X; Zhang B; Wei Y
Cancer Med; 2021 Jan; 10(2):471-482. PubMed ID: 33320433
[TBL] [Abstract][Full Text] [Related]
3. Mediastinal lymph node examination and survival in resected early-stage non-small-cell lung cancer in the surveillance, epidemiology, and end results database.
Osarogiagbon RU; Yu X
J Thorac Oncol; 2012 Dec; 7(12):1798-1806. PubMed ID: 23154551
[TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of malignant pleural effusion at presentation in patients with metastatic non-small-cell lung cancer.
Morgensztern D; Waqar S; Subramanian J; Trinkaus K; Govindan R
J Thorac Oncol; 2012 Oct; 7(10):1485-9. PubMed ID: 22982649
[TBL] [Abstract][Full Text] [Related]
5. The prognostic value of multiorgan metastases in patients with non-small cell lung cancer and its variants: a SEER-based study.
Yang J; Zhang Y; Sun X; Gusdon AM; Song N; Chen L; Jiang G; Huang Y
J Cancer Res Clin Oncol; 2018 Sep; 144(9):1835-1842. PubMed ID: 30003315
[TBL] [Abstract][Full Text] [Related]
6. Does Lymph Node Metastasis Have a Negative Prognostic Impact in Patients with NSCLC and M1a Disease?
Dai C; Ren Y; Xie D; Zheng H; She Y; Fei K; Jiang G; Chen C
J Thorac Oncol; 2016 Oct; 11(10):1745-54. PubMed ID: 27567989
[TBL] [Abstract][Full Text] [Related]
7. Systematic lymph node dissection is necessary for T1a non-small cell lung cancer.
Liu T; Liu H; Li Y
Asia Pac J Clin Oncol; 2015 Mar; 11(1):49-53. PubMed ID: 24787666
[TBL] [Abstract][Full Text] [Related]
8. The prognostic value of ratio-based lymph node staging in resected non-small-cell lung cancer.
Qiu C; Dong W; Su B; Liu Q; Du J
J Thorac Oncol; 2013 Apr; 8(4):429-35. PubMed ID: 23486264
[TBL] [Abstract][Full Text] [Related]
9. Lymph node ratio may predict the benefit of postoperative radiotherapy in non-small-cell lung cancer.
Urban D; Bar J; Solomon B; Ball D
J Thorac Oncol; 2013 Jul; 8(7):940-6. PubMed ID: 23695418
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological characteristics and lymph node metastasis pathway of non-small-cell lung cancer located in the left lingular division.
Shien K; Toyooka S; Soh J; Okami J; Higashiyama M; Kadota Y; Maeda H; Hayama M; Chida M; Funaki S; Okumura M; Miyoshi S
Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):791-6. PubMed ID: 25805399
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of the primary tumor location based on the hilar structures in non-small cell lung cancer with mediastinal lymph node metastasis.
Ito M; Yamashita Y; Miyata Y; Ohara M; Tsutani Y; Ikeda T; Misumi K; Harada H; Omori K
Lung Cancer; 2012 Apr; 76(1):93-7. PubMed ID: 22285532
[TBL] [Abstract][Full Text] [Related]
12. Association of lymph node involvement with the prognosis of pathological T1 invasive non-small cell lung cancer.
Zhang YK; Chai ZD; Tan LL; Wang ZY; Chen ZJ; Le HB; Zhu WY
World J Surg Oncol; 2017 Mar; 15(1):64. PubMed ID: 28302176
[TBL] [Abstract][Full Text] [Related]
13. Tumor, node and metastasis classification of lung cancer--M1a versus M1b--analysis of M descriptors and other prognostic factors.
Sánchez de Cos Escuín J; Abal Arca J; Melchor Íñiguez R; Miravet Sorribes L; Núñez Ares A; Hernández Hernández JR; García Arangüena L; Núñez Delgado M; Pavón Fernández MJ; Francisco Corral G; de Esteban Júlvez L; González Budiño MT; Abad Cavaco F; Ansótegui Barrera E; Andreo García F; Serra Mitjans M; Hernández Rodríguez H
Lung Cancer; 2014 May; 84(2):182-9. PubMed ID: 24629637
[TBL] [Abstract][Full Text] [Related]
14. Expression of HAb18G/CD147 and its localization correlate with the progression and poor prognosis of non-small cell lung cancer.
Xu XY; Lin N; Li YM; Zhi C; Shen H
Pathol Res Pract; 2013 Jun; 209(6):345-52. PubMed ID: 23602236
[TBL] [Abstract][Full Text] [Related]
15. [The place of surgery in metastatic non-small cell lung cancer].
Le Pimpec Barthes F; Mordant P; Pricopi C; Foucault C; Dujon A; Riquet M
Rev Mal Respir; 2012 Mar; 29(3):376-83. PubMed ID: 22440301
[TBL] [Abstract][Full Text] [Related]
16. Serum Human Epididymis Secretory Protein 4 (HE4) is a Potential Prognostic Biomarker in Non-Small Cell Lung Cancer.
Mo D; He F
Clin Lab; 2018 Sep; 64(9):1421-1428. PubMed ID: 30274019
[TBL] [Abstract][Full Text] [Related]
17. Including positive lymph node count in the AJCC N staging may be a better predictor of the prognosis of NSCLC patients, especially stage III patients: a large population-based study.
Fan Y; Du Y; Sun W; Wang H
Int J Clin Oncol; 2019 Nov; 24(11):1359-1366. PubMed ID: 31183778
[TBL] [Abstract][Full Text] [Related]
18. Choice of postoperative radiation for stage IIIA pathologic N2 non-small cell lung cancer: impact of metastatic lymph node number.
Wang S; Ma Z; Yang X; Wang Y; Xu Y; Xia W; Chen R; Qiu M; Jiang F; Yin R; Xu L; Xu K
Radiat Oncol; 2017 Dec; 12(1):207. PubMed ID: 29284511
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of clinical N0 metastatic non-small cell lung cancer.
Tamura T; Kurishima K; Watanabe H; Shiozawa T; Nakazawa K; Ishikawa H; Satoh H; Hizawa N
Lung Cancer; 2015 Jul; 89(1):71-5. PubMed ID: 25913230
[TBL] [Abstract][Full Text] [Related]
20. M1b Disease in the 8th Edition of TNM Staging of Lung Cancer: Pattern of Single Extrathoracic Metastasis and Clinical Outcome.
Park H; Dahlberg SE; Lydon CA; Araki T; Hatabu H; Rabin MS; Johnson BE; Nishino M
Oncologist; 2019 Aug; 24(8):e749-e754. PubMed ID: 30696724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]